Biomedical company improving surgical outcomes globally
COLUMBIA, Md., (September 19, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $25,000 Pre-Seed Rural Business Innovation Initiative (RBII) investment in BioEvanesce. This Rockville, Maryland-based company has developed a surgeon-friendly adhesive barrier that improves surgical outcomes.
BioEvanesce has developed an innovative hydrogel-based barrier and delivery system designed to improve surgical outcomes for patients undergoing abdominopelvic procedures. Since over 90% of these patients are at risk of developing post-surgical adhesions, the company’s solution aims to significantly reduce this common and serious complication.
“BioEvanesce is working to provide a global impact through their surgical product in hopes of impacting many individuals,” said Graham Dodge, vice president of Venture Development, TEDCO. “We look forward to supporting their vision and hope to see them generate long-term value in the biomedical field.”
TEDCO’s RBII fund was created to enhance technology commercialization and provide technical and business assistance to small and early-stage companies in rural Maryland. This assists companies that are considered start-ups and small technology-based businesses, offering comprehensive support such as mentorship, additional funding opportunities, and strategic business planning.
“We understand that entrepreneurs in rural Maryland are a vital part of our innovation story,” said Troy LeMaile-Stovall, CEO of TEDCO. “This reality has helped us secure top innovation and research and development performance rankings. At TEDCO, we are committed to providing the investments and resources that rural founders need to thrive, because a truly inclusive and resilient ecosystem must support innovation from every corner of Maryland.”
For more information about our investment opportunities, visit our page www.tedcomd.com/funding.